Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [ 225 Ac]Ac-DOTA-TDA-Lipiodol ® against hepatic tumors.
Anders JosefssonAngel G CortezHarikrishnan RajkumarJoseph D LatocheAmbika P JaswalKathryn E DayMohammadreza ZarisfiLora H RigattiZiyu HuangJessie R NedrowPublished in: EJNMMI radiopharmacy and chemistry (2023)
as a potential treatment option for treating hepatic tumors.